Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 31;144(9):e171-e191.
doi: 10.1161/CIR.0000000000001005. Epub 2021 Jul 28.

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

Michael H Criqui, Kunihiro Matsushita, Victor Aboyans, Connie N Hess, Caitlin W Hicks, Tak W Kwan, Mary M McDermott, Sanjay Misra, Francisco Ujueta; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifestyle and Cardiometabolic Health; Council on Peripheral Vascular Disease; and Stroke Council
Review

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

Michael H Criqui et al. Circulation. .

Erratum in

Abstract

Lower extremity peripheral artery disease (PAD) affects >230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes (other cardiovascular diseases such as coronary heart disease and stroke and leg outcomes such as amputation). Despite its prevalence and clinical importance, PAD has been historically underappreciated by health care professionals and patients. This underappreciation seems multifactorial (eg, limited availability of the first-line diagnostic test, the ankle-brachial index, in clinics; incorrect perceptions that a leg vascular disease is not fatal and that the diagnosis of PAD would not necessarily change clinical practice). In the past several years, a body of evidence has indicated that these perceptions are incorrect. Several studies have consistently demonstrated that many patients with PAD are not receiving evidence-based therapies. Thus, this scientific statement provides an update for health care professionals regarding contemporary epidemiology (eg, prevalence, temporal trends, risk factors, and complications) of PAD, the present status of diagnosis (physiological tests and imaging modalities), and the major gaps in the management of PAD (eg, medications, exercise therapy, and revascularization). The statement also lists key gaps in research, clinical practice, and implementation related to PAD. Orchestrated efforts among different parties (eg, health care providers, researchers, expert organizations, and health care organizations) will be needed to increase the awareness and understanding of PAD and improve the diagnostic approaches, management, and prognosis of PAD.

Keywords: AHA Scientific Statements; diagnosis; epidemiology; peripheral artery disease; prognosis; risk factors.

PubMed Disclaimer

Conflict of interest statement

The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.

Figures

Figure 1.
Figure 1.. Prevalence of peripheral artery disease by age in men (A and B) and women (C and D) in high-income countries (A and C) and low- and middle-income countries (B and D).
Reprinted from Fowkes et al. Copyright ©2013, with permission from Elsevier.
Figure 2.
Figure 2.. Adjusted hazard ratio of 3 major atherosclerotic diseases according to time since quitting smoking.
A, Peripheral artery disease (PAD). B, Coronary heart disease (CHD). C, Stroke. Reprinted from Ding et al. Copyright ©2019, with permission from the American College of Cardiology Foundation.
Figure 3.
Figure 3.. Hazard ratio (HR) of major atherosclerotic subtypes according to the presence versus absence of any retinopathy.
CHD indicates coronary heart disease; CLI, critical limb ischemia; and PAD, peripheral artery disease.
Figure 4.
Figure 4.. Cumulative incidence of major adverse cardiovascular events in the placebo group according to CVD status at baseline.
CVD indicates cardiovascular disease; MI, myocardial infarction; and PAD, peripheral artery disease.
See this image and copyright information in PMC

References

    1. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e726–e779. doi: 10.1161/CIR.0000000000000471 - DOI - PMC - PubMed
    1. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324. doi: 10.1001/jama.286.11.1317 - DOI - PubMed
    1. Pradhan AD, Aday AW, Beckman JA. The Big MAC attack on peripheral artery disease. Circulation. 2020;141:1211–1213. doi: 10.1161/CIRCULATIONAHA.120.045627 - DOI - PMC - PubMed
    1. Creager MA, Belkin M, Bluth EI, Casey DE Jr, Chaturvedi S, Dake MD, Fleg JL, Hirsch AT, Jaff MR, Kern JA, et al. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation /American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012;125:395–467 doi: 10.1161/CIR.0b013e31823299a1 - DOI - PubMed
    1. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WRC, Olin JW, Puschett JB, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation. 2006;113:e463–e654. doi: 10.1161/CIRCULATIONAHA.106.174526 - DOI - PubMed

MeSH terms